Speaker

Iliyan Iliev is an Immunologist, Laboratory Director and an Associate Professor at Weill Cornell Medical College, Cornell University, New York.

His pioneering research on the gut mycobiota defined the role of commensal fungi in innate mucosal and protective humoral immunity, and provided the first evidence for mycobiota involvement in the pathophysiology of Inflammatory Bowel Disease (IBD). The laboratory develops and applies translational, experimental and computational approaches to study the role of immunity and mycobiota early and later in life, upon therapeutic interventions and during conditions, such as inflammatory bowel disease, allergy, immunodeficiencies and gastrointestinal cancers, where fungi contribute to pathologies. Current effort in the laboratory, focused on the gut-bran axis and cancer, explores the unique neuro-modulatory and cancer-immunity modulating properties of fungi.

Dr. Iliev earned his PhD from the European School of Molecular Medicine and the University of Milan and was previously associated with the Tohoku University in Japan, LB Bulgaricum Plc., Meiji Co., Ltd and the Cedars Sinai Medical Center, UCLA in Los Angeles. Currently he is a Burroughs Wellcome Fund PATH Investigator, Irma T. Hirschl Scholar, Kenneth Rainin Foundation Innovator, CIFAR Fungal Kingdom: Threats and Opportunities Fellow and Cancer Research Institute Lloyd J. Old STAR Fellow. 

« Go Back